www.fdanews.com/articles/176097-profound-medical-snags-ce-mark-for-tulsa-pro
Profound Medical Snags CE Mark for TULSA-PRO
April 11, 2016
Profound Medical has received CE marking for its TULSA-PRO, a minimally invasive therapy for prostate care.
The therapy’s technology joins magnetic resonance imaging and transurethral ultrasound and closed-loop thermal feedback control to provide precise ablation.
The launch of the therapy in Europe will begin immediately. — Anisa Jibrell